UBS Group »

Kyverna Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $945k 157k 6.00
2025-06-30 $301k 98k 3.07
2025-03-31 $343k 178k 1.93
2024-12-31 $761k 203k 3.74
2024-09-30 $40k 8.2k 4.89
2024-06-30 $72k 9.6k 7.50
2024-03-31 $619k 25k 24.84